GlassScriptPhysician profile
Michael James Bauschard
NPI 1194251066
$4,321.68
in general payments reported to CMS, 2019-2025
15 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $80.66 · 2021: $1,049 · 2022: $880 · 2023: $407 · 2024: $567 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,201.16 | 2021-2025 | Inspire |
| Glaxosmithkline, LLC. | $601.19 | 2022-2025 | Nucala, Ojjaara |
| Integra Lifesciences Corporation | $397.30 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Stryker Corporation | $288.29 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $224.33 | 2024-2025 | Dupixent |
| Neurent Medical Limited | $151.21 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Acclarent, INC | $138.06 | 2023 | Trudi Nav Cable |
| Genzyme Corporation | $103.45 | 2022-2024 | |
| Karl Storz Endoscopy-America | $74.05 | 2021 | |
| Merck Sharp & Dohme LLC | $45.59 | 2023-2025 | Keytruda |
| Olympus America INC. | $20.51 | 2019 | |
| Smith+Nephew, INC. | $20.05 | 2023 | Grafix Pl |
| Rayner Intraocular Lenses Limited | $19.04 | 2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| Baxter Healthcare | $18.82 | 2019 | |
| Ambu INC. | $18.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bauschard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.